Response Genetics said this week that it has named Christine Meda as president of the company.
Kathleen Danenberg, who held the position previously, will continue to serve as CEO of the company.
Meda was most recently president and CEO of Arcxis Biotechnologies. She also founded and is president of RxDxLink; and has served as president and COO of Diamics. Prior to that, Meda held various positions at Roche Molecular Diagnostics, including vice president of business development and vice president of women's health.
BioNanomatrix has appointed Erik Holmlin as CEO, president, and director, succeeding Edward Erickson, who is now CEO at Saladax Biomedical.
Prior to joining BioNanomatrix, Holmlin served as CEO and president of GenVault, which merged with IntegenX last month. Prior to that he was chief commercial officer at Exiqon, where he was responsible for global sales, marketing, and clinical affairs for oncology services. In 2001, he founded molecular diagnostics company GeneOhm Sciences, which was acquired by Becton Dickinson in 2006.